<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2014.3205</article-id>
<article-id pub-id-type="publisher-id">or-32-01-0332</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Non-essential amino acids attenuate apoptosis of gastric cancer cells induced by glucose starvation</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>GANG</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref><xref rid="fn1-or-32-01-0332" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>DAI</surname><given-names>LEI</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref><xref rid="fn1-or-32-01-0332" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>LUO</surname><given-names>LAISHENG</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>WEN</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHANG</surname><given-names>CHENJING</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHU</surname><given-names>YIMIAO</given-names></name><xref rid="af2-or-32-01-0332" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>ZHONGTING</given-names></name><xref rid="af3-or-32-01-0332" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>WEN</given-names></name><xref rid="af2-or-32-01-0332" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>XIANG</given-names></name><xref rid="af3-or-32-01-0332" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>PAN</surname><given-names>WENSHENG</given-names></name><xref rid="af1-or-32-01-0332" ref-type="aff">1</xref><xref rid="af2-or-32-01-0332" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-or-32-01-0332"/></contrib></contrib-group>
<aff id="af1-or-32-01-0332">
<label>1</label>Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China</aff>
<aff id="af2-or-32-01-0332">
<label>2</label>Department of Gastroenterology, The Second Affiliated Hospital Binjiang Campus, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China</aff>
<aff id="af3-or-32-01-0332">
<label>3</label>Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China</aff>
<author-notes>
<corresp id="c1-or-32-01-0332">Correspondence to: Dr Wensheng Pan, Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, P.R. China, E-mail: <email>wspan223@163.com</email></corresp><fn id="fn1-or-32-01-0332">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>05</month>
<year>2014</year></pub-date>
<volume>32</volume>
<issue>1</issue>
<fpage>332</fpage>
<lpage>340</lpage>
<history>
<date date-type="received">
<day>06</day>
<month>02</month>
<year>2014</year></date>
<date date-type="accepted">
<day>23</day>
<month>04</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Energy and nutrition are essential requirements for all living cells, including cancer cells. In the initiating stage of cancer in organs, cancer cells grow fast and have inadequate supplies of glucose, oxygen and other nutrients due to deficient angiogenesis. Anaerobic conditions cause cancer cells to rely on glycolysis, which produces pyruvate and ATP that can be used by cancer cells to survive. However, glucose starvation may result in apoptosis or necrosis of cancer cells. It has been reported that autophagy is a consequence of glucose starvation and that amino acids are products of autophagy. The present study investigated whether amino acids may represent an alternative energy source for cancer cells undergoing glucose starvation. With non-essential amino acids, growth inhibition and apoptosis of gastric cancer cells induced by glucose starvation were attenuated compared with that of cells undergoing glucose starvation without amino acids, as measured by cell viability, apoptosis rates, membrane potential of mitochondria, and apoptosis-related genes. Meanwhile, both mitochondrial DNA copy number and amino acid transporter genes were increased compared with those in control cells. Non-essential amino acids prevented gastric cancer cells from glucose starvation-induced apoptosis.</p></abstract>
<kwd-group>
<kwd>non-essential amino acid</kwd>
<kwd>gastric cancer</kwd>
<kwd>apoptosis</kwd>
<kwd>glucose starvation</kwd>
<kwd>mitochondria</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Deregulating cellular metabolism is one of the hallmarks of cancer, first observed by Otto Warburg in the 20th century, and now known as the Warburg effect (<xref rid="b1-or-32-01-0332" ref-type="bibr">1</xref>&#x02013;<xref rid="b4-or-32-01-0332" ref-type="bibr">4</xref>). The Warburg effect in cancer cells is partially induced by rapid cell division, proliferation and anaerobic conditions as well as the requirement of small molecules for the subcellular construction of new cells (<xref rid="b1-or-32-01-0332" ref-type="bibr">1</xref>). Under anaerobic conditions, cancer cells convert glucose to pyruvate and then the pyruvate is transformed to lactic acid for the production of ATP and other cellular construction materials.</p>
<p>High glycolytic activity and inadequate glucose intake are contradictory factors in cancer cells. To handle this stress, the expression of glucose transporters, glucose-metabolizing enzymes and pyruvate dehydrogenase kinase are upregulated to promote glucose uptake; however, there is insufficient adaptive angiogenesis and blood supply (<xref rid="b5-or-32-01-0332" ref-type="bibr">5</xref>). To attenuate nutrient starvation, cancer cells utilize several compensatory approaches, such as autophagy (<xref rid="b6-or-32-01-0332" ref-type="bibr">6</xref>). Autophagy may be induced by high temperature, hormonal stimulation, low oxygen or nutrient starvation (<xref rid="b7-or-32-01-0332" ref-type="bibr">7</xref>,<xref rid="b8-or-32-01-0332" ref-type="bibr">8</xref>). In cancer cells, a lack of nutrient sources triggers autophagy, which can sustain the survival of malignant cells (<xref rid="b6-or-32-01-0332" ref-type="bibr">6</xref>). Cancer cells may undergo autophagy for back-up energy reserve to support self-survival (<xref rid="b6-or-32-01-0332" ref-type="bibr">6</xref>,<xref rid="b9-or-32-01-0332" ref-type="bibr">9</xref>), although autophagy may increase apoptosis and cell death (<xref rid="b10-or-32-01-0332" ref-type="bibr">10</xref>&#x02013;<xref rid="b12-or-32-01-0332" ref-type="bibr">12</xref>). The non-vascularized and metabolically stressed sites of tumors are usually accompanied by autophagy (<xref rid="b9-or-32-01-0332" ref-type="bibr">9</xref>).</p>
<p>During the early neonatal stages of newborns, starvation occurs in most mammals (<xref rid="b13-or-32-01-0332" ref-type="bibr">13</xref>). To overcome this life-threatening problem, autophagy is activated and self-holding proteins are degraded by autophagy to produce a pool of amino acids with which to attenuate nutrient starvation (<xref rid="b13-or-32-01-0332" ref-type="bibr">13</xref>). Meanwhile, nitrogen deprivation also triggers autophagy-dependent amino acid production (<xref rid="b14-or-32-01-0332" ref-type="bibr">14</xref>). Amino acids are enzymatically degraded and become nutrient molecules, which may sustain cancer cell survival while cancer cells are under conditions of low oxygen and blood supply.</p>
<p>To investigate the relationship between amino acids and cancer cells under low glucose conditions, we designed and performed a series of experiments. The present study determined whether amino acids can attenuate nutrient starvation of gastric cancer cells.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Cell lines and materials</title>
<p>Gastric cancer cells SGC7901, AGS and MGC803 were purchased from Shanghai Cell Collection (China) and cultured in RPMI-1640 medium (Gibco, USA) containing 2 mM L-glutamine, 100 U/ml penicillin, and 100 &#x003BC;g/ml streptomycin and supplemented with 10&#x00025; fetal bovine serum (FBS; HyClone, USA). The cell culture flasks were maintained in a humidified incubator at 37&#x000B0;C with a 5&#x00025; CO<sub>2</sub> atmosphere until they reached appropriate confluence. RPMI-1640 &#x0005B;&#x02212;&#x0005D; (no glucose, cat. 11879-020), standard RPMI-1640, MEM &#x0005B;100X, non-essential amino acids (NEAs); Invitrogen, cat. 11140-050&#x0005D;, and MEM amino acid solution (cat. 11130-051) were obtained from Life Technologies (USA). The JC-1 kit was obtained from Beyotime Biotech Inc. (China).</p></sec>
<sec>
<title>Cell viability assay</title>
<p>When grown to 60&#x02013;80&#x00025; confluence, gastric cells were trypsinized and seeded on 96-well plates at a density of 1&#x000D7;10<sup>4</sup> cells/well. The next day, complete medium containing 2,000, 1,000 or 500 mg/ml glucose was added into microplate wells, and a NEA solution was added into corresponding wells. Twenty microliters of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma Chemical Co., St. Louis, MO, USA) solution (5 mg/ml) were added to each well at intervals of 24, 48, 72 and 96 h after NEA infection. Plates were incubated at 37&#x000B0;C for 4 h, and 100 &#x003BC;l of a lysis buffer DMSO was then added to each well and mixed thoroughly for 10 min. Finally, absorbance values were determined at 570 nm by a microplate reader (Bio-Rad, USA) (<xref rid="b15-or-32-01-0332" ref-type="bibr">15</xref>).</p></sec>
<sec>
<title>Flow cytometry for apoptosis</title>
<p>To measure low-glucose-induced apoptosis, gastric cancer cells were pelleted in 6-well tissue plates and 16 h later, complete medium containing 2,000, 1,000 or 500 mg/ml glucose or complete medium containing 2,000, 1,000 or 500 mg/ml glucose with 2&#x000D7; NEAs (20 &#x003BC;l of 100&#x000D7; NEAs in 1 ml of experimental treatment medium) was added. Forty-eight hours later, gastric cancer cells were washed with phosphate-buffered saline (PBS), trypsinized with no-EDTA trypsin, centrifuged at 1,000 rpm for 5 min, repeatedly washed with PBS, and resuspended in 500 &#x003BC;l binding buffer/10<sup>6</sup> cells. Cells were then incubated with FITC-labeled Annexin V for 15 min on ice, followed by incubation with propidium iodide (PI) for another 15 min (BD Biosciences, USA) (<xref rid="b16-or-32-01-0332" ref-type="bibr">16</xref>). The apoptosis of gastric cancer cells was determined by flow cytometry.</p></sec>
<sec>
<title>Mitochondrial membrane potential detection by JC-1 staining</title>
<p>Gastric cancer cells were seeded in 6-well tissue plates at a density of 1&#x000D7;10<sup>5</sup> cells/well and grown to 60&#x02013;70&#x00025; confluence. Cells were then stimulated by experimental treatment medium for 48 h. The cells were washed twice with serum-free medium and incubated with a final concentration of 1 &#x003BC;M JC-1 (5,5&#x02032;,6,6&#x02032;-tetrachloro-1,1&#x02032;,3,3&#x02032;-tetraethylbenzimidazolylcarbocyanine iodide) in DMEM medium for 30 min at 37&#x000B0;C and 5&#x00025; CO<sub>2</sub> (<xref rid="b17-or-32-01-0332" ref-type="bibr">17</xref>,<xref rid="b18-or-32-01-0332" ref-type="bibr">18</xref>). After the medium was removed, each treatment group of cells was washed with PBS 3 times, and 100 &#x003BC;l of PBS was added to each well. Finally, the changes in the mitochondria membrane potential were determined by fluorescence-activated cell sorting (FACS; BD Biosciences) at excitation and emission wavelengths of 544 and 590 nm, respectively.</p></sec>
<sec>
<title>Total RNA isolation and quantitative real-time PCR</title>
<p>Total RNA from different treatment groups was extracted using TRIzol reagent (Invitrogen, USA), and the quality and concentration of RNAs were determined by UV spectrophotometry (Bio-Rad). Complimentary DNA (cDNA) was obtained, and quantitative real-time PCR (qRT-PCR) was then performed using a StepOne Plus instrument (Applied Biosystems, USA) with the following procedures: 95&#x000B0;C for 10 min, followed by 95&#x000B0;C for 15 sec, and 60&#x000B0;C for 1 min for 40 cycles. The relative expressions of the mRNAs of amino acid transporter genes (Lat1, Lat2 and h4F2hc) and cell apoptosis genes (Bcl-2, Bcl-xL, Bik and Bax) were detected by qRT-PCR, and the GAPDH gene was used as an internal control. The comparative CT method was used to calculate the relative expression level of these genes, and qRT-PCR was performed according to a previously described protocol (<xref rid="b19-or-32-01-0332" ref-type="bibr">19</xref>). Primers for these genes are listed in <xref rid="tI-or-32-01-0332" ref-type="table">Table I</xref>.</p></sec>
<sec>
<title>Mitochondrial DNA copy number detection</title>
<p>mtDNA copy number from experimental treatment medium-stimulated gastric cancer cells was determined by a standard protocol, as described in Current Protocols in Human Genetics (<xref rid="b20-or-32-01-0332" ref-type="bibr">20</xref>). Total genomic DNA was isolated with a QIAamp kit (Qiagen, Germany), according to the manufacturer&#x02019;s instructions. The method for mtDNA copy number detection based on qRT-PCR involved the utilization of a 107-bp-sized amplicon of mtDNA tRNA<sup>Leu(UUR)</sup> (forward primer, CACCCAAGAACAGGGTT TGT and reverse primer, TGGCCATGGGTATGTTGTTA); and an 86-bp-sized amplicon of &#x003B2;2-microglobulin (forward primer, TGCTGTCTCCATGTTTGATGTATCT and reverse primer, TCTCTGCTCCCCACCTCTAAGT) of nuclear DNA (nDNA) was used as an internal control (<xref rid="b20-or-32-01-0332" ref-type="bibr">20</xref>). The PCR procedure was as follows: 95&#x000B0;C for 10 min, followed by 95&#x000B0;C for 15 sec, and 60&#x000B0;C for 1 min for 40 cycles. PCR assays were performed in triplicate for each DNA sample. The expression of mtDNA copy number relative to the expression of nDNA was determined using the formula: 2&#x000D7;2<sup>(&#x00394;CT)</sup>, where &#x00394;CT is the difference in C<sub>T</sub> values between the &#x003B2;2-microglobulin gene and tRNA<sup>Leu(UUR)</sup> (<xref rid="b20-or-32-01-0332" ref-type="bibr">20</xref>).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>The statistical significance of the data between different groups was evaluated by performing an analysis of variance and Student&#x02019;s t-test using the SPSS 1 statistical software. p&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Amino acids help gastric cancer cells survive during glucose starvation</title>
<p>In solid tumors, low blood supply, glucose starvation and hypoxia are common due to the rapid proliferation of malignant cells (<xref rid="b21-or-32-01-0332" ref-type="bibr">21</xref>). Therefore, glucose starvation leads to apoptosis or necrosis of fast-growth cancer cells. Gastric cancer cells MGC803, AGS and SGC7901 were cultured in medium containing glucose concentrations of 2,000, 1,000 or 500 mg/ml in the presence or absence of 2&#x000D7; MEM amino acids. Cell viability detection assays were performed 24, 48 and 72 h later. As shown in <xref rid="f1-or-32-01-0332" ref-type="fig">Fig. 1</xref>, the cell viability at concentrations of 2,000 and 1,000 D-glucose (DG) was not significantly different between samples with and without NEA (<xref rid="f1-or-32-01-0332" ref-type="fig">Fig. 1A, B, D, E, G and H</xref>), but cells in 500 DG medium with NEA had a significantly higher survival rate compared with those in medium without NEA (<xref rid="f1-or-32-01-0332" ref-type="fig">Fig. 1C, F and I</xref>). Amino acids, therefore, promote gastric cancer cell survival under glucose starvation.</p></sec>
<sec>
<title>NEAs inhibit apoptosis caused by glucose starvation</title>
<p>To further investigate the effects of NEA on gastric cancer, we utilized flow cytometry to confirm the results of NEA-assisted gastric cancer cells surviving glucose starvation. Forty-eight hours after stimulation with conditional medium (medium containing glucose at a concentration of 2,000, 1,000 or 500 mg/ml with or without 2&#x000D7; MEM amino acids), cells were trypsinized and stained with PI and FITC-labeled Annexin V (<xref rid="b22-or-32-01-0332" ref-type="bibr">22</xref>). An obvious increase in the apoptosis rate was detected in the 500 DG groups (15.9&#x02013;44.1&#x00025;) compared with the 500 DG with NEA group in both the FITC/PI-positive (31.2&#x02013;54.3&#x00025;) and FITC-positive/PI-negative (19.2&#x02013;27.6&#x00025;) cells (<xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2A-c and -f</xref>; <xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2B-c and -f</xref>; <xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2C-c and -f</xref>). In contrast, no significant differences were found between the 2,000 and 1,000 DG groups (<xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2A-a, -b, -d and -e</xref>; <xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2B-a, -b, -d and -e</xref>; <xref rid="f2-or-32-01-0332" ref-type="fig">Fig. 2C-a, -b, -d and -e</xref>). NEA therefore decreased the apoptosis rate of gastric cancer cells in glucose-deficient medium.</p></sec>
<sec>
<title>Altered expression of the Bcl-2 gene family</title>
<p>Apoptosis is a programmed procedure involving various genes. The Bcl-2 gene family is a member of the apoptosis-associated genes and plays an important role in promoting or inhibiting apoptosis (<xref rid="b23-or-32-01-0332" ref-type="bibr">23</xref>,<xref rid="b24-or-32-01-0332" ref-type="bibr">24</xref>). The family contains Bcl-2, Bcl-xL, Bak, Bik and other genes (<xref rid="b24-or-32-01-0332" ref-type="bibr">24</xref>). The general function of Bcl-2 and Bcl-xL is anti-apoptotic and that of Bax and Bik is pro-apoptotic (<xref rid="b24-or-32-01-0332" ref-type="bibr">24</xref>,<xref rid="b25-or-32-01-0332" ref-type="bibr">25</xref>). Our data showed that the groups treated with 500 DG and 500 DG-AA medium had significantly different rates of proliferation and apoptosis. Thus, we evaluated the expression of Bcl-2, Bcl-xL, Bak and Bik in gastric cancer cells treated with 500 DG or 500 DG-AA medium. As shown in <xref rid="f3-or-32-01-0332" ref-type="fig">Fig. 3</xref>, Bcl-2 and Bcl-xL genes demonstrated decreased expression when gastric cancer cells were exposed to 500 DG medium compared with 500 DG-AA medium. Conversely, the expression of the Bik and Bax genes increased, which suggested that NEA sustained gastric cancer cells by inducing the expression of anti-apoptotic members of the Bcl-2 gene family and preventing the expression of pro-apoptotic members.</p></sec>
<sec>
<title>Overexpression of amino acid transporter genes induced by glucose starvation</title>
<p>The data presented above demonstrate that amino acids inhibit apoptosis. We hypothesized that the expression of amino acid transporters in the cell membrane may increase to fulfill the energy requirements of the cell. Thus, we examined the relative expression levels of amino acid transporter genes L-type amino acid transporter 1 (LAT1), LAT2 and h4F2hc. LAT1, as a transporter gene, is reported to be highly expressed in various human cancers (<xref rid="b26-or-32-01-0332" ref-type="bibr">26</xref>&#x02013;<xref rid="b32-or-32-01-0332" ref-type="bibr">32</xref>), and its expression is strongly correlated with that of another amino acid transporter gene, h4F2hc (<xref rid="b26-or-32-01-0332" ref-type="bibr">26</xref>). We performed qRT-PCR to determine transporter gene expression after 48 h of low-glucose culture and found that the decrease in glucose concentration led to the significant upregulation of amino acid transporters (LAT1 and h4Fhc). As shown in <xref rid="f4-or-32-01-0332" ref-type="fig">Fig. 4</xref>, LAT1 expression in MGC803 cells was upregulated under low-glucose conditions by 8.17- and 7.48-fold (1,000 and 500 DG, respectively) compared with the 2,000 DG group. LAT2 expression was decreased under low-glucose conditions, and the expression of h4F2hc was upregulated by 2.48- and 2.40-fold (1,000 and 500 DG, respectively; <xref rid="f4-or-32-01-0332" ref-type="fig">Fig. 4A</xref>) compared with the 2,000 DG group. Additionally, the ratios of LAT1, LAT2 and h4F2hc in the 1,000 and 500 DG groups compared with the 2,000 DG group were changed from 1.79 to 3.87, 2.42 to 0.69 and 5.09 to 5.14, respectively, in AGS cells (<xref rid="f4-or-32-01-0332" ref-type="fig">Fig. 4B</xref>). The corresponding ratios were 2.68 and 3.72, 20.23 and 6.20, and 3.41 and 4.50 in SGC7901 cells (<xref rid="f4-or-32-01-0332" ref-type="fig">Fig. 4C</xref>). Thus, glucose starvation was capable of upregulating amino acid transporter genes.</p></sec>
<sec>
<title>Mitochondrial content determination: DNA copy number</title>
<p>Mitochondrial disorders are complicated heterogeneous diseases that may be caused by molecular or cellular defects (<xref rid="b33-or-32-01-0332" ref-type="bibr">33</xref>,<xref rid="b34-or-32-01-0332" ref-type="bibr">34</xref>). It is clear that a constant number of mtDNA copies is essential for maintaining cell homeostasis (<xref rid="b35-or-32-01-0332" ref-type="bibr">35</xref>&#x02013;<xref rid="b37-or-32-01-0332" ref-type="bibr">37</xref>). Similarly, we investigated whether the copy number of mtDNA varied in gastric cancer cells during glucose starvation. We extracted the total genomic DNA of gastric cancer cells stimulated by 1,000 DG and 1,000 DG with NEA for 48 h and investigated the relative copy number of mtDNA compared to nDNA with real-time PCR. With nDNA as an internal control, the relative mtDNA copy number increased from 599 to 712, 597 to 783, and 461 to 523 in MGC803, AGS and SGC7901 cells, respectively, in the medium with NEA (p&lt;0.05) (<xref rid="f5-or-32-01-0332" ref-type="fig">Fig. 5</xref>).</p></sec>
<sec>
<title>NEAs prevent the loss of the mitochondrial membrane potential of gastric cancer cells during glucose starvation</title>
<p>Depolarization of the mitochondrial inner membrane resulting from ion channel opening is regarded as one of the signs of cell death. To examine whether low glucose and amino acids affected mitochondrial inner membrane potential, we used the voltage-sensitive fluorescent dye JC-1 to stain gastric cancer AGS cells that were treated for 24 h with low-glucose medium or medium with NEA. The ratio of JC-1 red (595 nm)/green (535 nm) represents the percentage of cells undergoing apoptosis. The ratio of JC-1 red/green in AGS cells is shown in <xref rid="f5-or-32-01-0332" ref-type="fig">Fig. 5</xref>. We determined that there were no significant differences in mitochondrial membrane potential between the groups cultured with or without NEA at 2,000 or 1,000 DG (2.45&#x02013;1.23 and 1.15&#x02013;3.19&#x00025;, respectively), but a significant difference was found between the 500 DG groups with and without NEA (78&#x00025; of the 500 DG group and 15.2&#x00025; of the 500 DG-AA group) (<xref rid="f6-or-32-01-0332" ref-type="fig">Fig. 6C and D</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Gastric cancer, similar to other types of solid cancer, requires angiogenesis when cancer cells undergo rapid growth and proliferation (<xref rid="b38-or-32-01-0332" ref-type="bibr">38</xref>,<xref rid="b39-or-32-01-0332" ref-type="bibr">39</xref>). Cancer cells require more energy support compared to normal cells, and glucose is a major source of cellular energy (<xref rid="b40-or-32-01-0332" ref-type="bibr">40</xref>). Otherwise, glucose is consumed not for ATP production but for cell growth and the production of new cells. Glycolysis is the major mechanism of glucose metabolism in cancer cells, which is called the Warburg effect, as it was observed by Otto Warburg for the first time in 1956 (<xref rid="b3-or-32-01-0332" ref-type="bibr">3</xref>,<xref rid="b41-or-32-01-0332" ref-type="bibr">41</xref>,<xref rid="b42-or-32-01-0332" ref-type="bibr">42</xref>). Without sufficient angiogenesis, glucose starvation or deprivation is common in fast-growing cancer cells, and autophagy may be an alternative energy source for cancer cells (<xref rid="b6-or-32-01-0332" ref-type="bibr">6</xref>,<xref rid="b9-or-32-01-0332" ref-type="bibr">9</xref>). Amino acids, as the products of autophagy, could serve as a back-up source of nutrients for rapidly growing malignant cells (<xref rid="b13-or-32-01-0332" ref-type="bibr">13</xref>,<xref rid="b14-or-32-01-0332" ref-type="bibr">14</xref>). Based on the above-referenced studies, we inferred that amino acids could prevent apoptosis of gastric cancer cells undergoing glucose deprivation.</p>
<p>Here, we presented evidence for the first time supporting the hypothesis that non-essential amino acids can attenuate glucose starvation-induced apoptosis of gastric cancer cells. Survival, apoptosis, the potential of mitochondria, mitochondria DNA copy number, and amino acid transporter proteins are all directly or indirectly regulated by non-essential amino acids added to low-glucose media. These data demonstrated that non-essential amino acids may be an alternative energy source for gastric cancer cells under glucose-starved conditions.</p>
<p>Energy deprivation of somatic or cancer cells could trigger marked reprogramming of cell homeostasis to facilitate the adjustment of cellular metabolism (<xref rid="b43-or-32-01-0332" ref-type="bibr">43</xref>,<xref rid="b44-or-32-01-0332" ref-type="bibr">44</xref>). To elucidate the bio-function of amino acids in gastric cancer cells undergoing glucose starvation, we adopted a strategy of treating cancer cells with culture medium containing a glucose concentration gradient and investigated whether amino acids performed important effects to attenuate glucose starvation. The results of a series of experiments measuring proliferation, apoptosis, and the expression of related genes showed that low glucose concentration could induce gastric cancer cells to undergo apoptosis, but non-essential amino acids could attenuate that effect. Several studies have mentioned that glucose starvation could result in apoptosis of cells though signaling pathways (<xref rid="b43-or-32-01-0332" ref-type="bibr">43</xref>,<xref rid="b45-or-32-01-0332" ref-type="bibr">45</xref>).</p>
<p>The amino acid transporter gene LAT1 has been reported to be upregulated in the membranes of many cancer cells (<xref rid="b27-or-32-01-0332" ref-type="bibr">27</xref>,<xref rid="b28-or-32-01-0332" ref-type="bibr">28</xref>,<xref rid="b46-or-32-01-0332" ref-type="bibr">46</xref>&#x02013;<xref rid="b48-or-32-01-0332" ref-type="bibr">48</xref>). This protein transports amino acids into cells and is different from two other amino acid transporter genes, namely LAT2 and h4F2hc (<xref rid="b49-or-32-01-0332" ref-type="bibr">49</xref>). Energy deprivation can trigger response systems to adjust the state of cells, and increased amino acid intake may be one of those responses.</p>
<p>Several recent studies have shown that amino acids are associated with proliferation in cancer (<xref rid="b50-or-32-01-0332" ref-type="bibr">50</xref>&#x02013;<xref rid="b54-or-32-01-0332" ref-type="bibr">54</xref>). Jain <italic>et al</italic> found that 219 metabolites were released from rapidly proliferating cancer cells, and glycine consumption and the glycine biosynthetic pathway were strongly correlated with the rate of proliferation of almost 60 cell lines (<xref rid="b50-or-32-01-0332" ref-type="bibr">50</xref>). Zhang <italic>et al</italic> reported that glycine may be a critical factor associated with tumor-initiating cells and tumorigenesis of non-small-cell lung cancer (<xref rid="b54-or-32-01-0332" ref-type="bibr">54</xref>). In <italic>Arabidopsis thaliana</italic>, low energy status induced the upregulation of the basic leucine zipper transcriptional factors bZIP1 and bZIP53, which are crucial factors in proline, asparagine, and branched amino acid metabolism in response to energy starvation (<xref rid="b55-or-32-01-0332" ref-type="bibr">55</xref>). Proline and asparagine are included in non-essential amino acids. Increasingly more evidence shows that amino acids may have a critical functional role in proliferation, resistance to anticancer drugs, invasion or metastasis of cancer cells. Amino acids are constructed units of proteins and additionally may serve as an energy resource such as glucose. As shown in the present study, non-essential amino acids were able to mitigate the stress caused by glucose starvation.</p>
<p>All cells and tissues have an amino acid sensor system that can help monitor the state of intercellular amino acids (<xref rid="b56-or-32-01-0332" ref-type="bibr">56</xref>,<xref rid="b57-or-32-01-0332" ref-type="bibr">57</xref>). In higher eukaryotic cells, mTOR1 is believed to regulate protein synthesis in the amino acid signaling pathway (<xref rid="b57-or-32-01-0332" ref-type="bibr">57</xref>). The protein mTOR is a central cell growth regulator and promotes cell growth and cell size by controlling protein synthesis (<xref rid="b56-or-32-01-0332" ref-type="bibr">56</xref>). At the same time, mTORC can be stimulated by or control amino acid metabolism through several key components (such as Rag GTPase), and the signaling is described in detail in a review (<xref rid="b56-or-32-01-0332" ref-type="bibr">56</xref>).</p>
<p>Mitochondria have important roles in various cellular activities, including apoptosis and energy metabolism (<xref rid="b58-or-32-01-0332" ref-type="bibr">58</xref>). The content of mitochondria (mitochondrial DNA copy number) changes with the changed status of cells and may increase or decrease (<xref rid="b59-or-32-01-0332" ref-type="bibr">59</xref>&#x02013;<xref rid="b62-or-32-01-0332" ref-type="bibr">62</xref>). In the present study, we found that non-essential amino acids maintained a constant mitochondria content in gastric cancer cells undergoing glucose starvation, which indicates that non-essential amino acids may reduce the decreasing effect on the content of mitochondria that are induced by glucose starvation and thus sustain cell viability (<xref rid="b63-or-32-01-0332" ref-type="bibr">63</xref>). The potential of mitochondria is associated with cell apoptosis and mitochondria DNA copy number and is also a marker of cell activity. All the effects that were observed in this study reflected the finding that non-essential amino acids could increase the activity of gastric cancer cells facing glucose starvation.</p>
<p>The results of the present study confirmed the hypothesis that non-essential amino acids and not total amino acid or glutamine levels were capable of promoting gastric cancer survival in cells under glucose starvation. The promoting effects of the non-essential amino acids may be achieved through the increased expression of amino acid transporter proteins, upregulation of the expression of anti-apoptotic genes, and mitochondrial content. Future studies should focus on the signaling pathways by which amino acids are regulated in response to low glucose conditions.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by grants from the National Health Key Special Fund (No. 200802112), the Health Department Fund (No. 2007A093), the Traditional Chinese Medicine Bureau Fund (No. 2007ZA019), the Natural Science Foundation of Zhejiang Province (Nos. Y2080001, Y12H160121 and Z2080514), the Key Project of Zhejiang Province (No. 2009C03012-5 and No. 2013C03044-5), and the National Natural Science Foundation of China (No. 81372302).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-32-01-0332"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><year>2011</year></element-citation></ref>
<ref id="b2-or-32-01-0332"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname><given-names>O</given-names></name></person-group><article-title>On respiratory impairment in cancer cells</article-title><source>Science</source><volume>124</volume><fpage>269</fpage><lpage>270</lpage><year>1956</year></element-citation></ref>
<ref id="b3-or-32-01-0332"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname><given-names>O</given-names></name></person-group><article-title>On the origin of cancer cells</article-title><source>Science</source><volume>123</volume><fpage>309</fpage><lpage>314</lpage><year>1956</year></element-citation></ref>
<ref id="b4-or-32-01-0332"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname><given-names>O</given-names></name><name><surname>Wind</surname><given-names>F</given-names></name><name><surname>Negelein</surname><given-names>E</given-names></name></person-group><article-title>The metabolism of tumors in the body</article-title><source>J Gen Physiol</source><volume>8</volume><fpage>519</fpage><lpage>530</lpage><year>1927</year></element-citation></ref>
<ref id="b5-or-32-01-0332"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denko</surname><given-names>NC</given-names></name></person-group><article-title>Hypoxia, HIF1 and glucose metabolism in the solid tumour</article-title><source>Nat Rev Cancer</source><volume>8</volume><fpage>705</fpage><lpage>713</lpage><year>2008</year></element-citation></ref>
<ref id="b6-or-32-01-0332"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Karantza-Wadsworth</surname><given-names>V</given-names></name><name><surname>White</surname><given-names>E</given-names></name></person-group><article-title>Role of autophagy in cancer</article-title><source>Nat Rev Cancer</source><volume>7</volume><fpage>961</fpage><lpage>967</lpage><year>2007</year></element-citation></ref>
<ref id="b7-or-32-01-0332"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Cell biology: autophagy and cancer</article-title><source>Nature</source><volume>446</volume><fpage>745</fpage><lpage>747</lpage><year>2007</year></element-citation></ref>
<ref id="b8-or-32-01-0332"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><article-title>Autophagy: process and function</article-title><source>Genes Dev</source><volume>21</volume><fpage>2861</fpage><lpage>2873</lpage><year>2007</year></element-citation></ref>
<ref id="b9-or-32-01-0332"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degenhardt</surname><given-names>K</given-names></name><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Beaudoin</surname><given-names>B</given-names></name><etal/></person-group><article-title>Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis</article-title><source>Cancer Cell</source><volume>10</volume><fpage>51</fpage><lpage>64</lpage><year>2006</year></element-citation></ref>
<ref id="b10-or-32-01-0332"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya</surname><given-names>P</given-names></name><name><surname>Gonz&#x000E1;lez-Polo</surname><given-names>RA</given-names></name><name><surname>Casares</surname><given-names>N</given-names></name><etal/></person-group><article-title>Inhibition of macroautophagy triggers apoptosis</article-title><source>Mol Cell Biol</source><volume>25</volume><fpage>1025</fpage><lpage>1040</lpage><year>2005</year></element-citation></ref>
<ref id="b11-or-32-01-0332"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colell</surname><given-names>A</given-names></name><name><surname>Ricci</surname><given-names>JE</given-names></name><name><surname>Tait</surname><given-names>S</given-names></name><etal/></person-group><article-title>GAPDH and autophagy preserve survival after apoptotic cytochrome <italic>c</italic> release in the absence of caspase activation</article-title><source>Cell</source><volume>129</volume><fpage>983</fpage><lpage>997</lpage><year>2007</year></element-citation></ref>
<ref id="b12-or-32-01-0332"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karantza-Wadsworth</surname><given-names>V</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Kravchuk</surname><given-names>O</given-names></name><etal/></person-group><article-title>Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis</article-title><source>Genes Dev</source><volume>21</volume><fpage>1621</fpage><lpage>1635</lpage><year>2007</year></element-citation></ref>
<ref id="b13-or-32-01-0332"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuma</surname><given-names>A</given-names></name><name><surname>Hatano</surname><given-names>M</given-names></name><name><surname>Matsui</surname><given-names>M</given-names></name><etal/></person-group><article-title>The role of autophagy during the early neonatal starvation period</article-title><source>Nature</source><volume>432</volume><fpage>1032</fpage><lpage>1036</lpage><year>2004</year></element-citation></ref>
<ref id="b14-or-32-01-0332"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onodera</surname><given-names>J</given-names></name><name><surname>Ohsumi</surname><given-names>Y</given-names></name></person-group><article-title>Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation</article-title><source>J Biol Chem</source><volume>280</volume><fpage>31582</fpage><lpage>31586</lpage><year>2005</year></element-citation></ref>
<ref id="b15-or-32-01-0332"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><etal/></person-group><article-title>microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity</article-title><source>Br J Cancer</source><volume>103</volume><fpage>1215</fpage><lpage>1220</lpage><year>2010</year></element-citation></ref>
<ref id="b16-or-32-01-0332"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasz</surname><given-names>B</given-names></name><name><surname>R&#x000E1;cz</surname><given-names>B</given-names></name><name><surname>Roth</surname><given-names>E</given-names></name><etal/></person-group><article-title>Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis</article-title><source>Peptides</source><volume>27</volume><fpage>87</fpage><lpage>94</lpage><year>2006</year></element-citation></ref>
<ref id="b17-or-32-01-0332"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gartlon</surname><given-names>J</given-names></name><name><surname>Kinsner</surname><given-names>A</given-names></name><name><surname>Bal-Price</surname><given-names>A</given-names></name><name><surname>Coecke</surname><given-names>S</given-names></name><name><surname>Clothier</surname><given-names>RH</given-names></name></person-group><article-title>Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity</article-title><source>Toxicol In Vitro</source><volume>20</volume><fpage>1569</fpage><lpage>1581</lpage><year>2006</year></element-citation></ref>
<ref id="b18-or-32-01-0332"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>MD</given-names></name><name><surname>O&#x02019;Neil</surname><given-names>JD</given-names></name><name><surname>Woehrling</surname><given-names>EK</given-names></name><etal/></person-group><article-title>A preliminary investigation into the impact of a pesticide combination on human neuronal and glial cell lines in vitro</article-title><source>PLoS One</source><volume>7</volume><fpage>e42768</fpage><year>2012</year></element-citation></ref>
<ref id="b19-or-32-01-0332"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappello</surname><given-names>C</given-names></name><name><surname>Zwergal</surname><given-names>A</given-names></name><name><surname>Kanclerski</surname><given-names>S</given-names></name><etal/></person-group><article-title>C/EBP&#x003B2; enhances NF-&#x003BA;B-associated signalling by reducing the level of I&#x003BA;B-&#x003B1;</article-title><source>Cell Signal</source><volume>21</volume><fpage>1918</fpage><lpage>1924</lpage><year>2009</year></element-citation></ref>
<ref id="b20-or-32-01-0332"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venegas</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dimmock</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>LJ</given-names></name></person-group><article-title>Real-time quantitative PCR analysis of mitochondrial DNA content</article-title><source>Curr Protoc Hum Genet</source><volume>Unit 19.17</volume><year>2011</year></element-citation></ref>
<ref id="b21-or-32-01-0332"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pola</surname><given-names>C</given-names></name></person-group><article-title>Cancer microenvironment: p53 acts in the hood</article-title><source>Nat Med</source><volume>19</volume><fpage>546</fpage><year>2013</year></element-citation></ref>
<ref id="b22-or-32-01-0332"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yermolaieva</surname><given-names>O</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Schinstock</surname><given-names>C</given-names></name><etal/></person-group><article-title>Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation</article-title><source>Proc Natl Acad Sci USA</source><volume>101</volume><fpage>1159</fpage><lpage>1164</lpage><year>2004</year></element-citation></ref>
<ref id="b23-or-32-01-0332"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnegan</surname><given-names>NM</given-names></name><name><surname>Curtin</surname><given-names>JF</given-names></name><name><surname>Prevost</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>B</given-names></name><name><surname>Cotter</surname><given-names>TG</given-names></name></person-group><article-title>Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions</article-title><source>Br J Cancer</source><volume>85</volume><fpage>115</fpage><lpage>121</lpage><year>2001</year></element-citation></ref>
<ref id="b24-or-32-01-0332"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardwick</surname><given-names>JM</given-names></name><name><surname>Soane</surname><given-names>L</given-names></name></person-group><article-title>Multiple functions of BCL-2 family proteins</article-title><source>Cold Spring Harb Perspect Biol</source><volume>5</volume><fpage>a008722</fpage><year>2013</year></element-citation></ref>
<ref id="b25-or-32-01-0332"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>D</given-names></name></person-group><article-title>Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis</article-title><source>FEBS J</source><volume>278</volume><fpage>403</fpage><lpage>413</lpage><year>2011</year></element-citation></ref>
<ref id="b26-or-32-01-0332"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaira</surname><given-names>K</given-names></name><name><surname>Oriuchi</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer</article-title><source>Am J Transl Res</source><volume>3</volume><fpage>468</fpage><lpage>478</lpage><year>2011</year></element-citation></ref>
<ref id="b27-or-32-01-0332"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukumoto</surname><given-names>S</given-names></name><name><surname>Hanazono</surname><given-names>K</given-names></name><name><surname>Komatsu</surname><given-names>T</given-names></name><name><surname>Iwano</surname><given-names>H</given-names></name><name><surname>Kadosawa</surname><given-names>T</given-names></name><name><surname>Uchide</surname><given-names>T</given-names></name></person-group><article-title>L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors</article-title><source>J Vet Med Sci</source><volume>75</volume><fpage>431</fpage><lpage>437</lpage><year>2013</year></element-citation></ref>
<ref id="b28-or-32-01-0332"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaira</surname><given-names>K</given-names></name><name><surname>Oriuchi</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma</article-title><source>Anticancer Res</source><volume>31</volume><fpage>4075</fpage><lpage>4082</lpage><year>2011</year></element-citation></ref>
<ref id="b29-or-32-01-0332"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaira</surname><given-names>K</given-names></name><name><surname>Oriuchi</surname><given-names>N</given-names></name><name><surname>Imai</surname><given-names>H</given-names></name><etal/></person-group><article-title>L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas</article-title><source>J Surg Oncol</source><volume>99</volume><fpage>433</fpage><lpage>438</lpage><year>2009</year></element-citation></ref>
<ref id="b30-or-32-01-0332"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkawa</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Masuko</surname><given-names>K</given-names></name><etal/></person-group><article-title>Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy</article-title><source>Biochem Biophys Res Commun</source><volume>406</volume><fpage>649</fpage><lpage>655</lpage><year>2011</year></element-citation></ref>
<ref id="b31-or-32-01-0332"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Amo</surname><given-names>EM</given-names></name><name><surname>Urtti</surname><given-names>A</given-names></name><name><surname>Yliperttula</surname><given-names>M</given-names></name></person-group><article-title>Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2</article-title><source>Eur J Pharm Sci</source><volume>35</volume><fpage>161</fpage><lpage>174</lpage><year>2008</year></element-citation></ref>
<ref id="b32-or-32-01-0332"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickens</surname><given-names>D</given-names></name><name><surname>Webb</surname><given-names>SD</given-names></name><name><surname>Antonyuk</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transport of gabapentin by LAT1 (SLC7A5)</article-title><source>Biochem Pharmacol</source><volume>85</volume><fpage>1672</fpage><lpage>1683</lpage><year>2013</year></element-citation></ref>
<ref id="b33-or-32-01-0332"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parr</surname><given-names>RL</given-names></name><name><surname>Mills</surname><given-names>J</given-names></name><name><surname>Harbottle</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mitochondria, prostate cancer, and biopsy sampling error</article-title><source>Discov Med</source><volume>15</volume><fpage>213</fpage><lpage>220</lpage><year>2013</year></element-citation></ref>
<ref id="b34-or-32-01-0332"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bratic</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name></person-group><article-title>The role of mitochondria in aging</article-title><source>J Clin Invest</source><volume>123</volume><fpage>951</fpage><lpage>957</lpage><year>2013</year></element-citation></ref>
<ref id="b35-or-32-01-0332"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purdue</surname><given-names>MP</given-names></name><name><surname>Hofmann</surname><given-names>JN</given-names></name><name><surname>Colt</surname><given-names>JS</given-names></name><etal/></person-group><article-title>A case-control study of peripheral blood mitochondrial DNA copy number and risk of renal cell carcinoma</article-title><source>PLoS One</source><volume>7</volume><fpage>e43149</fpage><year>2012</year></element-citation></ref>
<ref id="b36-or-32-01-0332"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Van Houten</surname><given-names>B</given-names></name></person-group><article-title>Alterations in bioenergetics due to changes in mitochondrial DNA copy number</article-title><source>Methods</source><volume>51</volume><fpage>452</fpage><lpage>457</lpage><year>2010</year></element-citation></ref>
<ref id="b37-or-32-01-0332"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>BC</given-names></name><name><surname>Hays</surname><given-names>L</given-names></name></person-group><article-title>Mitochondrial DNA copy number changes in human gliomas</article-title><source>Cancer Lett</source><volume>105</volume><fpage>167</fpage><lpage>173</lpage><year>1996</year></element-citation></ref>
<ref id="b38-or-32-01-0332"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitadai</surname><given-names>Y</given-names></name></person-group><article-title>Angiogenesis and lymphangiogenesis of gastric cancer</article-title><source>J Oncol</source><fpage>468725</fpage><year>2010</year></element-citation></ref>
<ref id="b39-or-32-01-0332"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maehara</surname><given-names>Y</given-names></name><name><surname>Hasuda</surname><given-names>S</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer</article-title><source>Clin Cancer Res</source><volume>4</volume><fpage>2129</fpage><lpage>2134</lpage><year>1998</year></element-citation></ref>
<ref id="b40-or-32-01-0332"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunt</surname><given-names>SY</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name></person-group><article-title>Aerobic glycolysis: meeting the metabolic requirements of cell proliferation</article-title><source>Annu Rev Cell Dev Biol</source><volume>27</volume><fpage>441</fpage><lpage>464</lpage><year>2011</year></element-citation></ref>
<ref id="b41-or-32-01-0332"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>EC</given-names></name><name><surname>Rathmell</surname><given-names>JC</given-names></name></person-group><article-title>New roles for pyruvate kinase M2: working out the Warburg effect</article-title><source>Trends Biochem Sci</source><volume>33</volume><fpage>359</fpage><lpage>362</lpage><year>2008</year></element-citation></ref>
<ref id="b42-or-32-01-0332"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Understanding the Warburg effect: the metabolic requirements of cell proliferation</article-title><source>Science</source><volume>324</volume><fpage>1029</fpage><lpage>1033</lpage><year>2009</year></element-citation></ref>
<ref id="b43-or-32-01-0332"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendivil-Perez</surname><given-names>M</given-names></name><name><surname>Jimenez-Del-Rio</surname><given-names>M</given-names></name><name><surname>Velez-Pardo</surname><given-names>C</given-names></name></person-group><article-title>Glucose starvation induces apoptosis in a model of acute T leukemia dependent on caspase-3 and apoptosis-inducing factor: a therapeutic strategy</article-title><source>Nutr Cancer</source><volume>65</volume><fpage>99</fpage><lpage>109</lpage><year>2013</year></element-citation></ref>
<ref id="b44-or-32-01-0332"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Influence of glucose starvation on the pathway of death in insect cell line Sl: apoptosis follows autophagy</article-title><source>Cytotechnology</source><volume>54</volume><fpage>97</fpage><lpage>105</lpage><year>2007</year></element-citation></ref>
<ref id="b45-or-32-01-0332"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moruno-Manch&#x000F3;n</surname><given-names>JF1</given-names></name><name><surname>P&#x000E9;rez-Jim&#x000E9;nez</surname><given-names>E</given-names></name><name><surname>Knecht</surname><given-names>E</given-names></name></person-group><article-title>Glucose induces autophagy under starvation conditions by a p38 MAPK-dependent pathway</article-title><source>Biochem J</source><volume>449</volume><fpage>497</fpage><lpage>506</lpage><year>2013</year></element-citation></ref>
<ref id="b46-or-32-01-0332"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Jutabha</surname><given-names>P</given-names></name><name><surname>Endou</surname><given-names>H</given-names></name><name><surname>Anzai</surname><given-names>N</given-names></name></person-group><article-title>c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells</article-title><source>Oncol Rep</source><volume>28</volume><fpage>862</fpage><lpage>866</lpage><year>2012</year></element-citation></ref>
<ref id="b47-or-32-01-0332"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haining</surname><given-names>Z</given-names></name><name><surname>Kawai</surname><given-names>N</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><etal/></person-group><article-title>Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas</article-title><source>BMC Clin Pathol</source><volume>12</volume><fpage>4</fpage><year>2012</year></element-citation></ref>
<ref id="b48-or-32-01-0332"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichinoe</surname><given-names>M</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><etal/></person-group><article-title>High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions</article-title><source>Pathol Int</source><volume>61</volume><fpage>281</fpage><lpage>289</lpage><year>2011</year></element-citation></ref>
<ref id="b49-or-32-01-0332"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khunweeraphong</surname><given-names>N</given-names></name><name><surname>Nagamori</surname><given-names>S</given-names></name><name><surname>Wiriyasermkul</surname><given-names>P</given-names></name><etal/></person-group><article-title>Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with &#x003B1;-alkyl moieties</article-title><source>J Pharmacol Sci</source><volume>119</volume><fpage>368</fpage><lpage>380</lpage><year>2012</year></element-citation></ref>
<ref id="b50-or-32-01-0332"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Nilsson</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation</article-title><source>Science</source><volume>336</volume><fpage>1040</fpage><lpage>1044</lpage><year>2012</year></element-citation></ref>
<ref id="b51-or-32-01-0332"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddocks</surname><given-names>OD</given-names></name><name><surname>Berkers</surname><given-names>CR</given-names></name><name><surname>Mason</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells</article-title><source>Nature</source><volume>493</volume><fpage>542</fpage><lpage>546</lpage><year>2013</year></element-citation></ref>
<ref id="b52-or-32-01-0332"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipp</surname><given-names>FV</given-names></name><name><surname>Ratnikov</surname><given-names>B</given-names></name><name><surname>De Ingeniis</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>JW</given-names></name><name><surname>Osterman</surname><given-names>AL</given-names></name><name><surname>Scott</surname><given-names>DA</given-names></name></person-group><article-title>Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma</article-title><source>Pigment Cell Melanoma Res</source><volume>25</volume><fpage>732</fpage><lpage>739</lpage><year>2012</year></element-citation></ref>
<ref id="b53-or-32-01-0332"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shyh-Chang</surname><given-names>N</given-names></name><name><surname>Locasale</surname><given-names>JW</given-names></name><name><surname>Lyssiotis</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Influence of threonine metabolism on <italic>S</italic>-adenosylmethionine and histone methylation</article-title><source>Science</source><volume>339</volume><fpage>222</fpage><lpage>226</lpage><year>2013</year></element-citation></ref>
<ref id="b54-or-32-01-0332"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WC</given-names></name><name><surname>Shyh-Chang</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis</article-title><source>Cell</source><volume>148</volume><fpage>259</fpage><lpage>272</lpage><year>2012</year></element-citation></ref>
<ref id="b55-or-32-01-0332"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>K</given-names></name><name><surname>Weltmeier</surname><given-names>F</given-names></name><name><surname>Ehlert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Heterodimers of the <italic>Arabidopsis</italic> transcription factors bZIP1 and bZIP53 reprogram amino acid metabolism during low energy stress</article-title><source>Plant Cell</source><volume>23</volume><fpage>381</fpage><lpage>395</lpage><year>2011</year></element-citation></ref>
<ref id="b56-or-32-01-0332"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>Amino acid signaling in TOR activation</article-title><source>Annu Rev Biochem</source><volume>80</volume><fpage>1001</fpage><lpage>1032</lpage><year>2011</year></element-citation></ref>
<ref id="b57-or-32-01-0332"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>RF</given-names></name></person-group><article-title>Amino acid sensing mechanisms: an Achilles heel in cancer?</article-title><source>FEBS J</source><volume>279</volume><fpage>2624</fpage><lpage>2631</lpage><year>2012</year></element-citation></ref>
<ref id="b58-or-32-01-0332"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crimi</surname><given-names>M</given-names></name><name><surname>Rigolio</surname><given-names>R</given-names></name></person-group><article-title>The mitochondrial genome, a growing interest inside an organelle</article-title><source>Int J Nanomed</source><volume>3</volume><fpage>51</fpage><lpage>57</lpage><year>2008</year></element-citation></ref>
<ref id="b59-or-32-01-0332"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thyagarajan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Nelson</surname><given-names>H</given-names></name><name><surname>Barcelo</surname><given-names>H</given-names></name><name><surname>Koh</surname><given-names>WP</given-names></name><name><surname>Yuan</surname><given-names>JM</given-names></name></person-group><article-title>Mitochondrial DNA copy number is associated with breast cancer risk</article-title><source>PLoS One</source><volume>8</volume><fpage>e65968</fpage><year>2013</year></element-citation></ref>
<ref id="b60-or-32-01-0332"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>R</given-names></name><name><surname>Ghosh</surname><given-names>SK</given-names></name><name><surname>Choudhury</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India</article-title><source>PLoS One</source><volume>8</volume><fpage>e57771</fpage><year>2013</year></element-citation></ref>
<ref id="b61-or-32-01-0332"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnot</surname><given-names>S</given-names></name><name><surname>Samuels</surname><given-names>DC</given-names></name><name><surname>Hesters</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mutation dependance of the mitochondrial DNA copy number in the first stages of human embryogenesis</article-title><source>Hum Mol Genet</source><volume>22</volume><fpage>1867</fpage><lpage>1872</lpage><year>2013</year></element-citation></ref>
<ref id="b62-or-32-01-0332"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>Q</given-names></name></person-group><article-title>Reduced mitochondrial DNA copy number in Chinese patients with osteosarcoma</article-title><source>Transl Res</source><volume>161</volume><fpage>165</fpage><lpage>171</lpage><year>2013</year></element-citation></ref>
<ref id="b63-or-32-01-0332"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>LC</given-names></name><name><surname>Di Benedetto</surname><given-names>G</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><article-title>During autophagy mitochondria elongate, are spared from degradation and sustain cell viability</article-title><source>Nat Cell Biol</source><volume>13</volume><fpage>589</fpage><lpage>598</lpage><year>2011</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-32-01-0332" position="float">
<label>Figure 1</label>
<caption>
<p>Non-essential amino acids promote gastric cancer cell survival under conditions of glucose starvation. Non-essential amino acids may help MGC803, AGS and SGC7901, three gastric cancer cell lines, resist low glucose. Cell growth in the 500 DG group was significantly greater than that in the 500 DG with NEA group (p&lt;0.05) (C, F and I). Others were not as high as that in the 500 DG with NEA group (A, B, D, E, G and H).</p></caption>
<graphic xlink:href="OR-32-01-0332-g00.gif"/></fig>
<fig id="f2-or-32-01-0332" position="float">
<label>Figure 2</label>
<caption>
<p>Apoptosis of gastric cancer cells induced by glucose starvation. (A) Apoptosis of MGC803 cells induced by glucose starvation. (B) Apoptosis of AGS cells induced by glucose starvation. (C) Apoptosis of SGC7901 cells induced by glucose starvation. FITC-labeled Annexin V and PI were both used as indices for apoptosis induced by medium containing 2,000, 1,000 or 500 mg/ml glucose (a&#x02013;c) with or without NEA (d&#x02013;f). (a, 2,000 DG group; b, 1,000 DG group; c, 500 DG group; d, 2,000 DG-AA group; e, 1,000 DG-AA group; and f, 500 DG-AA group).</p></caption>
<graphic xlink:href="OR-32-01-0332-g01.gif"/>
<graphic xlink:href="OR-32-01-0332-g02.gif"/>
<graphic xlink:href="OR-32-01-0332-g03.gif"/></fig>
<fig id="f3-or-32-01-0332" position="float">
<label>Figure 3</label>
<caption>
<p>Non-essential amino acids affect the expression of Bcl-2 family genes under glucose starvation conditions. Real-time PCR analysis of Bcl-2 family genes (Bcl-2, Bcl-xL, Bik and Bax) in three gastric cancer cell lines, MGC803, AGS and SGC7901, cultured in 500 DG (with or without NEA) for 48 h. NEA aided the cells by reducing the effects induced by glucose starvation. Data are representative of three experiments. (&#x02018;<sup>&#x0002A;</sup>&#x02019; represents a statistically significant difference, and &#x02018;<sup>&#x0002A;&#x0002A;</sup>&#x02019; represents a highly statistically significant difference).</p></caption>
<graphic xlink:href="OR-32-01-0332-g04.gif"/></fig>
<fig id="f4-or-32-01-0332" position="float">
<label>Figure 4</label>
<caption>
<p>Low glucose concentration upregulates amino acid transporter genes in gastric cancer cells. Amino acid transporter genes in low glucose-induced (A) MGC803 cells, (B) AGS cells, (C) SGC7901 cells.</p></caption>
<graphic xlink:href="OR-32-01-0332-g05.gif"/></fig>
<fig id="f5-or-32-01-0332" position="float">
<label>Figure 5</label>
<caption>
<p>Amino acids stimulate an increase in mitochondrial DNA (mtDNA) copy number in gastric cancer cells cultured in low-glucose medium. MGC803, AGS and SGC7901 cells were stimulated with medium containing 1,000 DG or 1,000 DG with NEA for 48 h, and the genomic DNA of these cells was extracted for real-time PCR detection. We calculated the relative amount of mtDNA using the formula 2&#x000D7;2<sup>(&#x00394;CT)</sup>. The amount of mtDNA increased slightly (599 to 712 in MGC803 cells, 597 to 783 in AGS cells and 461 to 523 in SGC7901 cells). DG, D-glucose; NEA, non-essential amino acids.</p></caption>
<graphic xlink:href="OR-32-01-0332-g06.gif"/></fig>
<fig id="f6-or-32-01-0332" position="float">
<label>Figure 6</label>
<caption>
<p>Membrane potential of mitochondria in gastric cancer AGS cells cultured in gradient concentrations of glucose and labeled with JC-1. (A) 2,000 DG group; (B) 1,000 DG group; (C) 500 DG group; (D) 2,000 DG with NEA group; (E) 1,000 DG with NEA group, and 500 DG with NEA group.</p></caption>
<graphic xlink:href="OR-32-01-0332-g07.gif"/></fig>
<table-wrap id="tI-or-32-01-0332" position="float">
<label>Table I</label>
<caption>
<p>Primers for amino acid transporter and apoptosis-related genes used in qRT-PCR.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Gene names</th>
<th align="center" valign="bottom">Primers</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">LAT1</td>
<td align="left" valign="top">F: TGTGCTGGCATTATACAGCG</td></tr>
<tr>
<td align="left" valign="top">LAT1</td>
<td align="left" valign="top">R: AGGTGATAGTTCCCGAAGTC</td></tr>
<tr>
<td align="left" valign="top">LAT2</td>
<td align="left" valign="top">F: TTTCCAGGAACCTGACATCG</td></tr>
<tr>
<td align="left" valign="top">LAT2</td>
<td align="left" valign="top">R: ACATTGCAGTGACATAAGCG</td></tr>
<tr>
<td align="left" valign="top">h4F2hc</td>
<td align="left" valign="top">F: CTCAGGCAAGGCTCCTGACT</td></tr>
<tr>
<td align="left" valign="top">h4F2hc</td>
<td align="left" valign="top">R: GGCAGGGTGAAGAGCATCA</td></tr>
<tr>
<td align="left" valign="top">Bax</td>
<td align="left" valign="top">F: GATGCGTCCACCAAGAAGCT</td></tr>
<tr>
<td align="left" valign="top">Bax</td>
<td align="left" valign="top">R: CGGCCCCAGTTGAAGTTG</td></tr>
<tr>
<td align="left" valign="top">Bcl-xL</td>
<td align="left" valign="top">F: ACCCCAGGGACAGCATATCA</td></tr>
<tr>
<td align="left" valign="top">Bcl-xL</td>
<td align="left" valign="top">R: TGCGATCCGACTCACCAATA</td></tr>
<tr>
<td align="left" valign="top">Bcl-2</td>
<td align="left" valign="top">F: TCCGCATCAGGAAGGCTAGA</td></tr>
<tr>
<td align="left" valign="top">Bcl-2</td>
<td align="left" valign="top">R: AGGACCAGGCCTCCAAGCT</td></tr>
<tr>
<td align="left" valign="top">Bik</td>
<td align="left" valign="top">F: CTTGATGGAGACCCTCCTGTATG</td></tr>
<tr>
<td align="left" valign="top">Bik</td>
<td align="left" valign="top">R: AGGGTCCAGGTCCTCTTCAGA</td></tr></tbody></table></table-wrap></floats-group></article>
